CTKB
Cytek Biosciences Inc
5.40$
+0.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.8% | 16.3% | 8.8% | 13.3% | 25.7% | 3.5% | -0.3% | 0.2% | -7.5% | -1.2% | -6.2% | 2.8% | -2.9% | |
| 5.3% | 4.2% | 5.5% | 5.3% | 5.5% | 4.8% | 7.0% | 6.6% | 5.9% | 4.9% | 6.4% | 6.2% | 5.8% | |
| 12.0% | 9.7% | 12.6% | 15.3% | 13.7% | 12.2% | 16.0% | 14.9% | 10.8% | 8.9% | 11.0% | 11.1% | 10.3% | |
| -11.0% | -6.6% | 4.1% | 17.4% | -19.3% | -9.6% | 7.3% | -1.7% | -6.8% | -5.6% | 20.4% | 8.7% | 3.0% | |
| 2.9% | 2.7% | 1.4% | 2.6% | 1.6% | 1.6% | 2.1% | 3.5% | 1.3% | 1.6% | 4.9% | 4.6% | 2.9% | |
| 89.8% | 49.9% | -12.8% | 4.3% | -30.7% | -110.4% | 22.8% | -36.0% | 36.2% | -3.0% | -61.4% | 14.6% | -1.4% | |
| 0.9% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -17.6% | -59.7% | -0.3% | -5.7% | -23.2% | -12.2% | -25.6% | -9.9% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | |
| – | – | – | – | -0.3% | 4.6% | -2.0% | 2.7% | 3.7% | -2.5% | 9.5% | -3.3% | 1.5% | |
| -17.2% | -58.0% | 3.6% | -3.7% | -23.5% | -6.3% | -27.8% | -5.7% | 3.7% | -2.0% | 9.0% | -1.7% | 1.9% | |
| 66.8% | 6.9% | 3.4% | 18.8% | -30.3% | -110.6% | -8.3% | -43.5% | 34.1% | -3.9% | -57.1% | 17.0% | -0.8% | |
| -11.7% | 13.7% | 7.4% | 10.7% | 24.1% | 1.9% | -2.4% | -3.2% | -8.7% | -2.9% | -11.1% | -1.8% | -5.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.